CIRRX
Price
$17.62
Change
-$0.01 (-0.06%)
Updated
Jul 8 closing price
Net Assets
8.03B
FIKJX
Price
$16.81
Change
-$0.05 (-0.30%)
Updated
Jul 8 closing price
Net Assets
186.77M
Interact to see
Advertisement

CIRRX vs FIKJX

Header iconCIRRX vs FIKJX Comparison
Open Charts CIRRX vs FIKJXBanner chart's image
Cohen & Steers Real Estate Securities R
Price$17.62
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets8.03B
Fidelity Advisor Real Estate Z
Price$16.81
Change-$0.05 (-0.30%)
VolumeN/A
Net Assets186.77M
CIRRX vs FIKJX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CIRRX vs. FIKJX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIRRX is a Buy and FIKJX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRRX has more cash in the bank: 8.03B vs. FIKJX (187M). CIRRX (2.15) and FIKJX (2.09) have matching dividends . CIRRX was incepted earlier than FIKJX: CIRRX (11 years) vs FIKJX (7 years). CIRRX (1.25) is less costly to investors than FIKJX (0.62). CIRRX is a more actively managed with annual turnover of: 35.00 vs. FIKJX (24.00). CIRRX (0) and FIKJX (0) have matching initial minimum investment requirements. CIRRX annual gain was more profitable for investors over the last year : 9.65 vs. FIKJX (4.28). CIRRX return over 5 years is better than : 38.19 vs. FIKJX (-0.59).
CIRRXFIKJXCIRRX / FIKJX
Total Expense Ratio1.250.62202%
Annual Report Gross Expense Ratio1.250.62202%
Fund Existence11 years7 years-
Gain YTD3.8741.473263%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets8.03B187M4,293%
Annual Yield % from dividends2.152.09103%
Returns for 1 year9.654.28226%
Returns for 3 years10.83-13.16-82%
Returns for 5 years38.19-0.59-6,509%
Returns for 10 years60.63N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSSNX29.00N/A
N/A
Loomis Sayles Small Cap Growth N
PRHSX76.46N/A
N/A
T. Rowe Price Health Sciences
WPSGX56.24N/A
N/A
AB Concentrated Growth Advisor
IVKSX22.50N/A
N/A
VY® Invesco Comstock S
UAPIX62.18N/A
N/A
ProFunds UltraSmall Cap Inv